Phenothiazine kinesin inhibitors

Details Phenothiazine kinesin inhibitors Phenothiazine kinesin inhibitors

2006-01-31

2006-01-31

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S042000, C544S044000, C544S046000, C544S041000, C514S225500, C514S225800

Reexamination Certificate

active

06992082

ABSTRACT:
Phenothiazine derivatives of formula (I) are disclosed. The compounds are inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation.

REFERENCES:
patent: 2784185 (1957-03-01), Schuler
patent: 2830987 (1958-04-01), Gailliot et al.
patent: 2901478 (1959-08-01), Schuler
patent: 6569853 (2003-05-01), Borisy et al.
patent: 1190463 (1965-04-01), None
patent: 19924148 (2000-12-01), None
patent: 0 346 239 (1989-12-01), None
patent: WO 01/30768 (2001-05-01), None
patent: WO 01/98278 (2001-12-01), None

Affiliated with

Also associated with

Rating

Phenothiazine kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenothiazine kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenothiazine kinesin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3586416